PERICARDITIS
Clinical trials for PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new PERICARDITIS trials appear
Sign up with your email to follow new studies for PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to tame painful, recurring heart inflammation
Disease control Recruiting nowThis study is testing a new drug called KPL-387 to see if it can effectively treat and prevent the return of recurrent pericarditis, a painful inflammation of the heart's lining. It will involve about 165 adults who continue to have flare-ups despite standard treatments. The rese…
Matched conditions: PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New drug aims to tame recurring heart inflammation
Disease control Recruiting nowThis study is testing a medication called KPL-387 for people with recurrent pericarditis, a painful inflammation around the heart. The main goal is to see if patients can safely switch from their current treatments to KPL-387 alone and stay free of flare-ups. Researchers will fol…
Matched conditions: PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Doctors unite to map mysterious childhood disease
Knowledge-focused Recruiting nowThis study aims to gather detailed information about CACP syndrome, a very rare genetic disorder that causes bent fingers, joint problems, hip issues, and sometimes heart inflammation in children. Researchers across Europe will collect health data from about 15 children already d…
Matched conditions: PERICARDITIS
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Apr 04, 2026 01:35 UTC
-
Tracking Vaccine-Related heart issues in young adults
Knowledge-focused Recruiting nowThis study aims to better understand heart inflammation that can occur after COVID-19 vaccination. Researchers will follow 400 people who developed heart symptoms after vaccination, tracking their health for up to 4 years. The study will compare these cases with healthy controls …
Matched conditions: PERICARDITIS
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC